UnitedHealth Group (NYSE:UNH) Stock Falls 1.7% – Should You Sell?

UnitedHealth Group Incorporated (NYSE:UNH) shares fell 1.7% during trading on Friday. The stock traded as low as $416.37 and last traded at $417.9670. 3,885,552 shares traded hands during mid-day trading, a decline of 47% from the average session volume of 7,335,360 shares. The stock had previously closed at $424.98.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Third-quarter beat and raised outlook support the shares. Adjusted EPS rose approximately 61% to $4.69, exceeding the $4.14 consensus estimate, while revenue reached $112.7 billion versus expectations of $111.3 billion. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in its cost controls and execution. UnitedHealth beat-and-raise quarter
• Positive Sentiment: Optum Health’s performance improved materially. The unit’s profit increased to $735 million, helping demonstrate operating leverage and contributing to UnitedHealth’s post-earnings recovery. Optum Health profit surge
• Positive Sentiment: Analyst expectations and valuation support remain favorable. Erste Group raised its FY2026 EPS estimate to $20.55 from $19.86 and its FY2027 estimate to $23.29 from $22.51. Mizuho also lifted its price target to $500 from $493 and maintained an “outperform” rating, implying additional upside from the referenced price. Mizuho raises UnitedHealth price target
• Neutral Sentiment: Investor attention and value-based coverage may increase trading interest. Zacks highlighted heightened investor attention and characterized UNH as a value stock, but these are sentiment and screening signals rather than new fundamental developments. Zacks value-stock analysis
• Negative Sentiment: Higher 2027 Medicare costs could pressure affordability and margins. The planned increase in costs for seniors may create political and utilization concerns, potentially offsetting some of the recent earnings momentum. Healthcare stocks also faced broader sector pressure in recent trading. UnitedHealth 2027 Medicare costs

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Truist Financial lifted their price target on UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. TD Cowen reiterated a “hold” rating and set a $402.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Evercore lifted their target price on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research report on Tuesday, July 7th. Bank of America reaffirmed a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a research report on Monday, July 20th. Finally, Robert W. Baird decreased their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a research note on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $463.80.

UnitedHealth Group Price Performance

The stock has a market capitalization of $375.16 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 1.51 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The company’s 50-day simple moving average is $388.15 and its 200-day simple moving average is $389.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s payout ratio is currently 53.00%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is currently owned by company insiders.

Institutional Trading of UnitedHealth Group

Several hedge funds and other institutional investors have recently modified their holdings of the stock. City State Bank lifted its position in UnitedHealth Group by 5.6% during the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock worth $173,000 after acquiring an additional 25 shares during the last quarter. Murphy Pohlad Asset Management LLC grew its position in shares of UnitedHealth Group by 0.5% in the third quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock valued at $1,947,000 after purchasing an additional 25 shares during the last quarter. LFG Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after purchasing an additional 27 shares during the period. Synergy Financial Group LTD lifted its holdings in UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 27 shares during the last quarter. Finally, Ares Financial Consulting LLC boosted its stake in UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after purchasing an additional 28 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.